Navigation Links
Jeunesse Global Announces New Medical Advisory Board Member and Admittance Into the Direct Selling Association (DSA).
Date:8/29/2011

ALTAMONTE SPRINGS, Fla., Aug. 29, 2011 /PRNewswire-iReach/ -- Jeunesse Global, a network marketing company headquartered in Orlando, FL with offices worldwide has recently announced the appointment of Dr. Vincent Giampapa to its Medical Advisory Board, further strengthening the company's reputation and credibility within the international network marketing industry and communities. Corresponding with this major announcement, they also reported admittance into the DSA, achieving another important and strategic milestone.

Both announcements come at a crucial and defining time for the company. With preparations well underway for the Jeunesse MOMENTUM International Conference this September in Orlando, FL, the event is expected to draw together large numbers of distributors from all over the globe.

Dr. Vincent Giampapa

"Biotechnology is advancing so quickly that in order for Jeunesse to stay at the forefront of the anti-aging movement, we felt it was critical that we establish relationships with the most innovative doctors and researchers," said Founder/COO Wendy Lewis.

Vincent C. Giampapa, M.D., F.A.C.S. is a Board Certified Plastic Reconstructive Surgeon and Assistant Clinical Professor of Plastic and Reconstructive Surgery at the University of Medicine and Dentistry of New Jersey. He is Director of the Plastic Surgery Center Internationalé and The Giampapa Institute for Anti-Aging Medical Therapy in Montclair, New Jersey. Dr. Giampapa is internationally recognized as an innovator in new cosmetic and surgical techniques, and instrumentation, as well as a pioneer in the field of anti-aging medicine.

He received his M.D. degree from Mt. Sinai Medical School in New York, New York and continued his medical training in plastic surgery. Upon completion of his plastic surgical training, he completed a year of microsurgery and hand fellowship at New York University Medical Center. Dr. Giampapa is a Fellow of the American College of Surgeons and has served as Research Fellow for such other prestigious institutes as Columbia Presbyterian Medical Center in New York, New York. He was also the Director of Microsurgery and Re-plantation Surgery at the University of Medicine and Dentistry of New Jersey. He is published in numerous academic journals, including Annals of Plastic Surgery, Journal of Plastic Reconstructive Surgery, Journal of Reconstructive Microsurgery, and Journal of AntiAging Medicine.

A founding member of the American Academy of Anti-Aging Medicine, Dr. Giampapa served as the first President of the American Board of Anti-Aging Medicine. He is also one of the first Board Certified anti-aging physicians in the world. He is the author of the first and only medical textbook on anti-aging medicine and age management for aesthetic surgeons and has authored five consumer titles on the topic, including: Breaking the Aging Code and The Anti-Aging Solution: 5 Simple Steps to Looking and Feeling Young.

Dr. Giampapa served as a consultant for NASA and has been awarded over a dozen patents from the United States Government for unique cell culture delivery techniques, as well as new drug delivery systems and surgical instrument designs. Dr. Giampapa has been featured in myriad national magazines, and radio and television programs, including CNN, WABC-TV, Fox News Channel, Geraldo, Joan Rivers, Phil Donahue, and Anderson Cooper.

"I am excited to be part of the Jeunesse team and to be able to bring to a worldwide audience the latest science and technology to help people across the globe age optimally and improve their health span," said Dr. Giampapa. "After all, our health and quality time is our most precious asset. Jeunesse is without a doubt, poised to be the worldwide leader in the anti-aging product arena."

The DSA

DSA members must agree to follow a comprehensive ethics code that commits them to fair business practices in dealing with consumers and Distributors. The rules are far-reaching, covering such issues as buyback policies, inventory loading, earnings representations, and deceptive recruiting practices. DSA members are companies that manufacture or deal in goods or services intended to reach the consumer through a personal sales contact.

The cornerstone of the DSA commitment to ethical business practices and consumer service is its Code of Ethics. Every member company pledges to abide by the code's standards and procedures as a condition of admission and continuing membership in the DSA. The DSA Code of Ethics speaks to both the consumer and the seller. It ensures that member companies will make no statements or promises that might mislead either consumers or prospective sales people.*

About Jeunesse Global

Jeunesse Global is a leading network marketing company based out of Orlando, FL that specializes in providing anti-aging solutions based on cutting-edge science, such as adult stem cell technology, DNA repair, and nutrigenomics. Products are made in the U.S.A. and are exclusively formulated for Jeunesse. With a multi-lingual customer service and back office support team, global enrollment system, and in-house programming already in place, the company is fully operational in eight countries across the globe, with shipping available to 77 countries. For more information, please visit www.jeunesseglobal.com.

Media Contact

Lucy West

Director of Marketing and Sales

407-862-9100

marketing@jeunesseglobal.com

Follow us on Facebook!

facebook.com/TheScienceOfYouthfulAging

*http://www.dsa.org

Jeunesse Global and the Jeunesse Global logo are trademarks or registered trademarks of Jeunesse Global, LLC in the U.S. and/or other countries.

Media Contact: Lucy West Jeunesse Global, LLC, 407-862-9100, marketing@jeunesseglobal.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Jeunesse Global, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. IndiaMART.com to Step Up B2B Matchmaking at Global Trade Events
2. FMC Corporation Announces Exclusive Global Development and Supply Agreements for Chr. Hansen Biological Products
3. Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
4. Global Genetic Testing Market Analysis
5. ReportsnReports - Global Hospital Information Systems, Mobile Health Applications, Electric Vehicle Market Research Reports
6. MarketsandMarkets: Global Biochip (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Market to Reach $5.6 Billion by 2015
7. Global bioterrorism threat analyzed for world animal health office
8. Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule Revamilast
9. Global Microbiology Testing Market: Facilities, Test Volumes, and Sales Forecasts by Country
10. Scientists pinpoint river flow associated with cholera outbreaks, not just global warming
11. Lilly Global Giving Puts Power of Philanthropy in Employees Hands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: ... the three months ended December 31, 2016. ... and diagnostics company that develops and commercializes proprietary technologies and ... ... the commercial milestones achieved in fiscal 2016," said Andrew ...
(Date:2/21/2017)... ... 21, 2017 , ... Genedata, a leading provider of advanced ... establishment of Genedata Limited as a new subsidiary in the United Kingdom. The ... science informatics. Creating the UK subsidiary reinforces Genedata’s commitment to collaborate closely with ...
(Date:2/21/2017)... IL (PRWEB) , ... February ... ... of the Life -Sciences division, Treximo will pair its $200M operational capacity ... results-based consulting and project management in areas affecting quality and operational management. ...
(Date:2/21/2017)... VANCOUVER, British Columbia , Feb. 21, 2017 /PRNewswire/ ... that apatorsen results from two randomized Phase 2 clinical trials ... 2017 Genitourinary Cancers Symposium, held February 16 th - 18 ... from trials in bladder and prostate cancers demonstrated apatorsen was ... standard-of-care treatments. ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):